Physician profile
Terry Mueller
NPI 1891849691
$2,285.69
in general payments reported to CMS, 2019-2025
11 companies · $57.16 in 2025
The $57.16 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2021: $193 · 2023: $35.98 · 2024: $1,756 · 2025: $57.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,418 · Food and Beverage: $432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,417.60 |
| Food and Beverage | $431.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Team 1, LLC | $1,472.23 | 2024-2025 | |
| Arthrex, INC. | $277.65 | 2024 | |
| Wishbone Medical INC. | $169.04 | 2021 | |
| Smith+Nephew, INC. | $110.78 | 2019-2025 | Evos, Trigen Intertan |
| Pacira Pharmaceuticals Incorporated | $103.64 | 2019 | |
| Next Science LLC | $43.71 | 2019 | |
| Osteoremedies, LLC | $31.25 | 2019 | |
| Bioventus LLC | $24.11 | 2021 | |
| Baxter Healthcare | $22.88 | 2019 | |
| Solventum Corporation | $17.24 | 2025 | Prevena |
| Gilead Sciences, INC. | $13.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Mueller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.